Related references
Note: Only part of the references are listed.20+yr without leukemic or fibrotic transformation in essential thrombocythemia or polycythemia vera: predictors at diagnosis
Ayalew Tefferi et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2008)
Host genetic variation contributes to phenotypic diversity in myeloproliferative disorders
Animesh Pardanani et al.
BLOOD (2008)
Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms
A. Tefferi et al.
LEUKEMIA (2008)
Familial chronic myeloproliferative disorders: Clinical phenotype and evidence of disease anticipation
Elisa Rumi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003
Ingemar Turesson et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Thrombosis in myeloproliferative disorders: Prevalence, prognostic factors, and the role of leukocytes and JAK2V617F
Akyalew Tefferi et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2007)
Oncogenes in myeloproliferative disorders
Ayalew Tefferi et al.
CELL CYCLE (2007)
JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders
Elisa Rumi et al.
CANCER (2006)
Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders
Robert Kralovics et al.
BLOOD (2006)
Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders
Christine Bellanne-Chantelot et al.
BLOOD (2006)
Discordant distribution of JAK2V617F mutation in siblings with familial myeloproliferative disorders
A Pardanani et al.
BLOOD (2006)
Lessons from familial myeloproliferative disorders
R Skoda et al.
SEMINARS IN HEMATOLOGY (2005)
Management of patients with polycythaemia vera:: results of a survey among Swedish haematologists
B Andreasson et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2005)
The JAK2V617F mutation is acquired secondary to the predisposing alteration in familial polycythaemia vera
H Cario et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Methods for testing familial aggregation of diseases in population-based samples: Application to Hodgkin lymphoma in Swedish registry data
RM Pfeiffer et al.
ANNALS OF HUMAN GENETICS (2004)
Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia
F Passamonti et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease
R Kralovics et al.
BLOOD (2003)
A long-term retrospective study of young women with essential thrombocythemia
A Tefferi et al.
MAYO CLINIC PROCEEDINGS (2001)
Share Paper
